Medicor Research Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Sudbury Canada (2005)

Organization Overview

First Clinical Trial
2007
NCT00506298
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Medicor Research Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

bezafibrate (Bezalip) (1 trial)

diflunisal (dolobid) (1 trial)

Drugs in Phase 1 Trials (1)

fluorescein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3